Latest Updates
-
South Indian Style Buttermilk Recipe: A Refreshing Breakfast Delight -
Horoscope for Today June 08, 2026 - Small Choices Bring Calm Progress -
Authentic Indian Style Arrabiata Pasta Recipe -
Saree, But Make It Denim: Madhuri Dixit’s Denim Saree Look Breaks The Internet -
Think Twice Before Eating Street Food Wrapped In Newspaper, FSSAI Issues Warning -
Pride Month 2026: Inspiring LGBTQIA+ Firsts In India That Built Visibility, Representation And Change -
World Food Safety Day 2026: Can Carrot Extract Help Fake Ghee Evade Detection? An IIT-BHU Study Reveals How -
Easy Aloo Posto Recipe: A Bengali Lunch Delight -
Who Was Salim Kumar? The National Award Winner Behind Countless Laughs Passes Away At 56 -
Adhik Bhanu Saptami 2026: Significance, Puja Vidhi, Surya Mantras And The Role Of Ravi Yoga And Adhik Maas
Personalized Blood Tests For Cancer Patients

Boffins have used data from the whole genome sequencing of cancer patients to develop individualized blood tests which he believes can help physicians tailor patients' treatments.
"We believe this is the first application of newer generations of whole-genome sequencing that could be clinically useful for cancer patients.Using this approach, we can develop biomarkers for potentially any cancer patient." says Victor Velculescu, M.D., Ph.D., associate professor of oncology and co-director of the cancer biology Johns Hopkins."
In a report on the work, published in the February 24 issue of Science Translational Medicine, show that unlike any other kind researches they are studying the rearrangements of large chunks of DNA rather than changes in a single DNA letter among billions of others. They term it their new approach Personalized Analysis of Rearranged Ends (PARE).
Such DNA rearrangements are widely known to occur exclusively in cancer cells, not normal ones, making them ideal biomarkers for cancer.
Using six sets of cancerous and normal tissue samples taken from four colorectal and two breast cancer patients, the Johns Hopkins team used next-generation DNA sequencing methods to catalogue the genome sequence data of each patient.
After investigators identified DNA rearrangements in patients' tumor samples, they looked for similar changes in DNA shed from tumors into the patients' blood.
Taking and matching these samples, they amplified DNA found in the blood and determined that these tests were sensitive enough to detect rearranged tumor DNA in these samples.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications